and a whole lot more…

For FY17, $THC expects revenue to be in the range of $19.7-20.1Bil and net income from continuing operations to be in the range of $107-133MM. The company expects FY17 diluted EPS and adjusted EPS from continuing operations to be about $1.05-1.30 per share.

$THC and St. Luke’s Hospital, an independent, non-profit
healthcare provider, have entered into a definitive agreement for St. Luke’s to
purchase Des Peres Hospital as well as Tenet-owned physician practices and
other hospital-affiliated operations in St. Louis. The transaction is expected
to be completed early in 2018.

$THC and Baylor Scott & White Health have agreed to sell
Baylor Scott & White Medical Center - White Rock, a 218-bed hospital
located in Dallas, Texas, to Pipeline Health, LLC. The hospital is part of a JV
partnership with Baylor Scott & White Health, in which $THC is the minority
owner. The transaction is expected to be completed in 1Q18.

For FY18, $THC expects its net income to be in the range of $65-70MM with EPS of about $0.63-0.68. Adj. EPS is expected to be about $1.07-1.36. Net operating revenue is expected to be about $17.8-18.2Bil.

$THC said it would explore a sale of its subsidiary Conifer. The company expects to make a decision regarding the sale during the first half of 2018. Goldman, Sachs & Co. LLC as its financial advisor and Kirkland & Ellis LLP are the legal advisor.

$THC has increased the size of its previously announced cost reduction initiative by $100MM. The company now expects to achieve $200MM of annualized savings by the end of 2018. $THC has also started a process to refresh the composition of its BoD. The board currently consists of 12 directors.

$THC announced that Sandi Karrmann has been named SVP and Chief
Human Resources Officer, effective immediately. Ms. Karrmann replaces Robb
Webb, who has retired from the company. She will report directly to Ron
Rittenmeyer, Executive Chairman and CEO.

$THC announced that Chairman and CEO Trevor Fetter will step down
from his roles as Director and CEO at the earlier of March 15, 2018 or when a
successor is appointed. Current independent lead director Ronald A. Rittenmeyer
will become Executive Chairman effective immediately. Russell Reynolds
Associates will conduct a search for a new CEO.

$THC called for the redemption of the entire $250 million aggregate principal amount of its outstanding 8% Senior Notes due 2020. The Notes will be redeemed on Sept. 11, 2017 at a redemption price equal to 101.333% of the principal amount of the notes being redeemed.

$THC is planning a private offering of $3.78Bil of its senior secured and unsecured Notes through a private placement. The proceeds from the offering will be used to refinance $3.541Bil of its outstanding Notes, after payment of fees and expenses.

$AMED signed a deal to buy home health and hospice operations in Arizona, Illinois, Massachusetts and Texas from $THC. Healthcare company Amedisys has announced six acquisitions since Dec. 2015, deploying about $125MM in capital.

For FY17, $THC expects revenue to be in the range of $19.7-20.1Bil and net income from continuing operations to be in the range of $107-133MM. The company expects FY17 diluted EPS and adjusted EPS from continuing operations to be about $1.05-1.30 per share.

During 4Q16, $THC's net operating revenue in Hospital Operations and other segment fell 6.3% YoY to $4.14Bil, due to divestment of hospitals. Net Operating revenue of the Ambulatory Segment rose 20.4% to $478MM and revenue of Conifer's segment rose 4.7% to $402MM.

$THC and $UNH renewed national relationship for four years. This ensures all $UNH commercial and Medicare Advantage plan participants have continued in-network access to $THC's hospitals, outpatient centers and employed physicians across the country.

$THC completed its private offering of $750MM aggregate principal
amount of senior secured second lien notes maturing in 2022. The net proceeds will
be used, after payment of fees and expenses, to repay debt outstanding under the
company’s senior secured revolving credit facility and for general corporate
purposes.

$THC completed
its private offering of $750MM aggregate principal amount of senior secured
second lien notes maturing in 2022. The net proceeds will be used, after
payment of fees and expenses, to repay debt outstanding under the company’s senior
secured revolving credit facility and for general corporate purposes.

$THC announced
the appointment of Octavio Diaz, M.D., as Chief Medical Officer, effective
December 1. Dr. Diaz will report to Eric Evans, President of Hospital
Operations. Dr. Diaz currently serves as the CMO for $THC’s Florida and
Northeast Regions, which includes 19 acute care hospitals, outpatient
facilities and urgent care centers.

$THC has appointed two new independent directors to its BoD. The
new directors are John P. Byrnes, former chairman and CEO of Lincare Holdings,
Inc., and Peter M. Wilver, EVP and Chief Administrative Officer of Thermo
Fisher Scientific Inc.

As previously disclosed on Aug. 1, 2016, $THC will make settlement payments of about $514MM and pay about $3MM of related fees and expenses. The company expects to make these payments during 4Q16 using available liquidity, including cash and borrowings under its revolving credit facility.